PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,777,990 | -47.3% | 882,552 | -4.4% | 0.00% | -50.0% |
| Q2 2023 | $37,556,914 | -10.7% | 923,455 | +6.3% | 0.00% | -20.0% |
| Q1 2023 | $42,068,000 | +127789.6% | 868,453 | +0.8% | 0.01% | +25.0% |
| Q4 2022 | $32,894 | -99.9% | 861,770 | +5.3% | 0.00% | -33.3% |
| Q3 2022 | $41,099,000 | +18.4% | 818,719 | -5.5% | 0.01% | +20.0% |
| Q2 2022 | $34,700,000 | +17.8% | 866,195 | +9.7% | 0.01% | +25.0% |
| Q1 2022 | $29,466,000 | +17.2% | 789,735 | +25.1% | 0.00% | +33.3% |
| Q4 2021 | $25,149,000 | +13.8% | 631,405 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $22,109,000 | +0.6% | 594,166 | +14.3% | 0.00% | 0.0% |
| Q2 2021 | $21,981,000 | +23.1% | 520,041 | +37.9% | 0.00% | +50.0% |
| Q1 2021 | $17,859,000 | +24.2% | 377,165 | +60.1% | 0.00% | 0.0% |
| Q4 2020 | $14,374,000 | +79.9% | 235,528 | +39.3% | 0.00% | +100.0% |
| Q3 2020 | $7,990,000 | -11.6% | 169,026 | -5.1% | 0.00% | -50.0% |
| Q2 2020 | $9,039,000 | +27.2% | 178,149 | +11.8% | 0.00% | 0.0% |
| Q1 2020 | $7,107,000 | +30.5% | 159,323 | +40.5% | 0.00% | +100.0% |
| Q4 2019 | $5,446,000 | +646.0% | 113,380 | +425.5% | 0.00% | – |
| Q3 2019 | $730,000 | -11.7% | 21,574 | +12.6% | 0.00% | – |
| Q2 2019 | $827,000 | +46.6% | 19,166 | +27.7% | 0.00% | – |
| Q1 2019 | $564,000 | +19.5% | 15,003 | +9.1% | 0.00% | – |
| Q4 2018 | $472,000 | -19.5% | 13,750 | +10.4% | 0.00% | – |
| Q3 2018 | $586,000 | +59.2% | 12,458 | +14.0% | 0.00% | – |
| Q2 2018 | $368,000 | +68.8% | 10,924 | +35.3% | 0.00% | – |
| Q1 2018 | $218,000 | +51.4% | 8,072 | -6.7% | 0.00% | – |
| Q4 2017 | $144,000 | -97.9% | 8,651 | -98.6% | 0.00% | -100.0% |
| Q4 2016 | $6,765,000 | -23.6% | 620,075 | -1.9% | 0.00% | 0.0% |
| Q3 2016 | $8,854,000 | +264.7% | 631,962 | +82.7% | 0.00% | +100.0% |
| Q2 2016 | $2,428,000 | +94.7% | 345,941 | +78.7% | 0.00% | – |
| Q1 2016 | $1,247,000 | -81.7% | 193,539 | -7.8% | 0.00% | -100.0% |
| Q4 2015 | $6,801,000 | +55.9% | 209,926 | +28.5% | 0.00% | +100.0% |
| Q3 2015 | $4,362,000 | -35.4% | 163,360 | +16.4% | 0.00% | -50.0% |
| Q2 2015 | $6,755,000 | +18.9% | 140,338 | +50.3% | 0.00% | +100.0% |
| Q1 2015 | $5,682,000 | +44.9% | 93,375 | +23.3% | 0.00% | 0.0% |
| Q4 2014 | $3,921,000 | +31.3% | 75,737 | +11.6% | 0.00% | 0.0% |
| Q3 2014 | $2,987,000 | – | 67,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |